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The study and the exploitation of membrane proteins for drug screening applications requires a
controllable and reliable method for their delivery into an artificial suspended membrane platform
based on lab-on-a-chip technology. In this work, a polymeric device for forming lipid bilayers
suitable for electrophysiology studies and biosensor applications is presented. The chip supports a
single bilayer and is configured for controlled protein delivery through on-chip microfluidics. In
order to demonstrate the principle of protein delivery, the potassium channel KcsA was
reconstituted into proteoliposomes, which were then fused with the suspended bilayer on-chip.
Fusion of single proteoliposomes with the membrane was identified electrically. Single channel
conductance measurements of KcsA in the on-chip bilayer were recorded and these were
compared to previously published data obtained with a conventional planar bilayer system.
Introduction
Ion channels are of considerable importance in biological cell
membranes for many reasons, including the regulation of ion
concentrations involved in electrical signalling within nerve,
muscle and other living cells. Moreover, ion channels exhibit a
number of distinctive characteristics, including highly specific,
ion-selective filtering, where control and activation is through
a variety of mechanisms, depending upon the function and
nature of the cell.
1,2
Ion channels thus have the potential for use as extremely
specific, sensitive biosensors and for use in drug screening
technologies
3,4 by exploiting transmembrane ion movement in
an artificial and controlled environment.
5–7 These properties
would be especially beneficial if channels were integrated into a
lipid bilayer membrane system within a microfluidic chip
architecture, thus reproducing the natural environment of the
protein and combining the advantages of electronic and optical
recording, microfluidics and automated control.
8–11
In recent decades, numerous investigations on ion channel
behaviour have been reported, including studies on gating
mechanisms and channel selectivity,
12,13 primarily by means
of two main approaches: patch-clamp
14–17 and black lipid
membrane (BLM) techniques.
18–23 Both methods are widely
used to probe the electrical and chemical functionality of
ion channels.
There are many advantages in developing an on-chip BLM
technology. For instance, simultaneous electrical and optical
measurement of fluorescently labelled ion channels can be
performed, providing information about conformational
changes
24 and protein functionality.
11 However, a number of
technological issues have to be addressed if this technology
is to be adopted, particularly in terms of reliability and
semi-automation of the process. Currently, a high degree of
manual expertise is required to form an artificial membrane
either on conventional apparatus or on-chip. Even when
microfabricated structures are used, BLMs are still commonly
still made either by painting lipid with a rod over the device
aperture,
25,26 or by alternative techniques where manual
intervention is required (i.e. removal of excess lipid solution
with cotton).
22 BLMs have also been made within microfluidic
chips using solvent extraction through a polydimethylsiloxane
(PDMS) microfluidic channel, although this technique is not
yet fully developed.
23
Patch-clamp techniques measure protein behaviour in the
native cell and therefore obviate the requirement for protein
over-expression and reconstitution. In the conventional
method, immobile single cells are patched with a glass pipette.
Recent chip-based methods require single cells to be sucked
over and onto a micro-aperture to form a tight seal between
the membrane and the orifice.
14,17 This process requires
human skill and expertise, and activation of a single channel
gating mechanism is not always easy to achieve.
16 In view of
the advantages of chip-based systems, a number of research
groups are developing semi-automated patch-clamp arrays
based on microfluidic platforms,
14–17 but few results on single
channel measurement have been published.
The artificial BLM approach offers a valuable alternative to
the patch-clamp method: it does not require live cells, but does
require adequate supplies of functionally active proteins.
Generally, large proteins (50–500 kDa) do not reliably self-
insert into membranes (with the exception of the medium sized
OmpF and a-hemolysin (approximately 35 kDa))
19,27 in the
way that small fusogenic peptides do (e.g., gramicidin,
alamethicin and valinomycin).
22,25 Therefore, a reliable
method for controlled delivery and fusion of functionally
active proteins into suspended bilayer membranes is required.
This is one of the main issues facing the development of BLM,
chip-based, drug screening systems.
In this paper, we describe the formation of BLMs within a
microfluidic chip and a technique for delivering membrane
proteins to the bilayer. To demonstrate this, the potassium
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successfully delivered to an on-chip BLM using a vesicle fusion
technique, which was optimised for the chip-system. The
method is simple and reliable and could be implemented within
a generic single molecule biosensing platform. The aim of this
work was to develop a system for on-chip electrophysiology,
using proteo-liposome fusion to incorporate large proteins into
a BLM within a microfluidic device.
Protein delivery to bilayer membrane
A proteoliposome is a unilamellar lipid vesicle into which
protein molecules have been reconstituted. These vesicles have
been used for ion channel delivery into bilayer membranes by
many authors.
28,29 From 1980 onwards, several delivery
techniques have been optimised, and a range of parameters
identified as important for inducing the vesicles to fuse with a
membrane.
30–33 Amongst these, a salt gradient across the
membrane and a means for moving vesicles towards the
bilayer membrane play an important role.
Conventional technique
In the conventional approach, proteoliposomes are fused with
a suspended lipid bilayer by creating a salt gradient across the
membrane.
32,34 If protein electrical activity is not seen after
vesicle injection, the BLM is either broken and reformed
35 or a
solution of the proteoliposomes is painted directly onto the
aperture using a rod.
36 Generally, these procedures lead to
protein incorporation and the appearance of channel activity
either immediately or within a few minutes.
37 However, these
methods are not particularly amenable to chip-based systems.
Nystatin–ergosterol (N/E) technique
In 1990, Woodbury and Miller proposed an improved method
for vesicle fusion, which also enabled electrical detection of
fusion events.
38 This technique meant that it was possible to
estimate the number of functionally reconstituted channel
proteins in the BLM. In this method, the proteoliposomes
contain nystatin (a trans membrane antibiotic) and ergosterol
(a plant sterol). The vesicles are introduced into the cis
compartment of an ergosterol-free bilayer, across which a salt
gradient has been established. The higher salt concentration
(typically 450 to 600 mM) is on the cis side (where the vesicles
are added), with a lower salt concentration (150 mM) on the
trans side.
The cis side is continuously stirred, inducing the vesicles to
randomly collide with the bilayer. When the liposomes contact
the BLM, they are subjected to a positive hydrostatic pressure,
caused by an efflux of water from the trans side (low salt),
through the BLM and therefore into the vesicle. This induces
swelling and stressing of the liposome, leading to fusion with
the membrane.
40 The nystatin and ergosterol forms a complex
within the vesicle (Fig 1a) creating electrically conducting
pores. When a vesicle fuses with the ergosterol-free bilayer, the
pores incorporate into the bilayer and, in the presence of a DC
potential (typically 100 mV), a transient current spike is
measured. The current through these pores is transient because
immediately after fusion the ergosterol diffuses from the
Fig. 1 (a) Schematic diagram showing the mechanisms for vesicle fusion with a BLM. The vesicle is loaded with KcsA channels and nystatin–
ergosterol pores. After fusion the latter disassemble within a few seconds, whilst the potassium channels remain active. (b) Current trace of a vesicle
fusion event, showing channel activity; data obtained using conventional BLM apparatus. The fusion is marked by a large transient current spike,
which decays when the nystatin–ergosterol pore disassembles. A 450 mM KCl gradient is present across the BLM (150 mM, pH 4, 10 mM HEPES–
600 mM, pH 7.4, 10 mM HEPES), to induce vesicle fusion. A 100 mV voltage potential was maintained throughout the process (the relative
polarity has no effect on the fusion process).
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pore, and returning the current to the baseline (Fig. 1a).
40 Ion
channels can be reconstituted into these liposomes, so that
after a fusion event, the protein is the only functional channel
remaining in the BLM. A current trace showing a proteolipo-
some fusion event followed by KcsA channel activity, obtained
using conventional BLM apparatus, is presented in Fig. 1b.
KcsA potassium channels do not spontaneously incorporate
into a BLM, therefore these proteins were used to demonstrate
the generic applicability of the N/E technique for protein
delivery into an on-chip BLM.
Bilayer on chip
Chip-based bilayer technologies present a number of challenges
compared with conventional bilayer systems. The reduced
dimensions (volume decreased from mL to mL), lead to an
increase in the surface-to-volume ratio, together with the
impracticality of manually manipulating the electrolyte, as is
done in a conventional system. However, microfluidics offers
advantages, including automatic injection, and exchange or
perfusion of buffers and vesicles. The rate of vesicle fusion
events is related to the degree of liquid agitation,
40,41 which is
easier to control in a chip system, compared to conventional
apparatus.
Device structure and on-chip BLM formation
Devices for forming BLMs were fabricated from poly(methyl
methacrylate) (PMMA) and polytetrafluoroethylene (PTFE)
(Fig. 2a) using a combination of hot embossing and solvent
bonding techniques, as previously described.
42
The device comprises three layers: a PMMA base layer
(125 mm thick), a PMMA or PTFE middle layer (50 mm) that
contains the aperture for BLM formation, and a PMMA well
as the upper layer (3 mm). The lower channel (which is
connected to the top well through the aperture) was fabricated
either by hot embossing a PMMA sheet, or by cutting a
channel in double-sided adhesive tape, which was subsequently
used to bond the bottom and middle layers.
The bilayer membrane (Fig. 2b) was formed using an ‘‘air-
exposure technique’’,
43 controlled by on-chip fluidics. The
method for forming the bilayer is as follows. After filling the
entire device with buffer, the upper well was drained through
the connecting channel (OUT in Fig. 2c). The hydrophobic
characteristics of the middle layer and the position of the
draining channel are such that when the buffer is removed
from the top well, the solution in the lower channel remains
unchanged.
A small volume (,0.5 mL) of lipid solution (7 : 3 1-palmi-
toyl-2-oleoyl-sn-glycero-3-phospho-rac-1-glycerol : 1-palmi-
toyl-2-oleoyl-sn-glycero-3-phosphoethanolamine (POPE :
POPG), Avanti Polar Lipids, Alabama, USA) was then
pipetted into the well. Following a further injection of buffer
(IN, Fig. 2c), the well was again drained and the remaining
lipid film left exposed to air for a short period of time (10–40 s).
During this period, the lipid film began to thin. As the lower
layer of the device was produced from transparent PMMA
film, the thinning of the lipid film was observed optically. Once
a lipid membrane had formed across the majority of the
aperture, the well was re-filled by a final injection of buffer.
The BLM capacitance and transmembrane current were
monitored during the entire process. This technique has been
intensively tested with a yield of approximately 90%.
43
Experiments show that flow control is not a critical issue,
provided that the middle layer is sufficiently hydrophobic
(contact angle .90u) and that the surface is cleaned using
solvents prior to the experiments.
Proteoliposome reconstitution
Proteins were reconstituted in N/E vesicles using a modifica-
tion of a previously reported method.
39 This alternative
procedure is advantageous for the incorporation of large
protein molecules, because steps such as vesicle extrusion,
freeze-thawing and sonication, which could damage proteins,
are not used.
KcsA with an N-terminal hexahistidine tag was over-
expressed and purified as previously described.
44 A combina-
tion of POPE : POPG : ergosterol, at molar ratios of 6 : 3 : 1
and 5.5 : 3 : 1.5 respectively, were mixed in chloroform, dried,
and re-suspended in buffer (10 mM HEPES, 450 mM KCl
pH 7.4) containing 40 mM b-D-octyl glucoside to give a final
total lipid concentration of 10 mg mL
21. The sample (1–2 mL)
was then sonicated to optical clarity in a bath sonicator.
KcsA (40 mg) was mixed with the lipid sample to give a
Fig. 2 (a) A photograph of a polymeric device used for forming
BLMs: 1. fluid inlet and outlet; 2. bottom channel (trans side); 3. top
well (cis side). An aperture (100 mm diameter) is laser/mechanically
drilled in the PMMA (or PTFE) film (50 mm thickness) in the centre of
the well, providing a connection from the lower fluidic channel to the
upper well. (b) Optical transmission photograph of a bilayer formed
across a PTFE aperture (dark area) surrounded by the annulus (bright
area). (c) A cross section of the chip. In the upper half of the device (cis
side), two microfluidic channels are used for delivery of liquids and
perfusion of buffer (IN and OUT). The bottom channel is always filled
with buffer and the ion channel current is recorded through Ag/AgCl
electrodes inserted into one of the bottom channel inlets.
1178 | Lab Chip, 2007, 7, 1176–1183 This journal is  The Royal Society of Chemistry 200722 000 : 1 molar ratio of lipid : KcsA tetramer. Detergent was
removed by addition of 80 mg of washed SM2 Bio-Beads
(mesh size 20–50, Bio-Rad) followed, after one hour, by a
second addition of 80 mg Bio-Beads.
45 After a further hour,
the sample of reconstituted vesicles (150–350 nm diameter, as
estimated from light scattering) was removed from the Bio-
Beads and kept on ice until use. Alternatively, proteoliposomes
were stored at 4 uC for two weeks without loss of channel
functionality. Nystatin (Fluka), diluted in anhydrous methanol
(7 mL at 2.5 mg mL
21), was added to an aliquot of the
ergosterol-containing proteoliposomes (100 mL) and additional
buffer (100 mL of 450 mK KCl, 10 mM HEPES, pH 7.4). The
final sample was left to rest for approximately 60 min at 4 uC
to allow the nystatin to incorporate into the vesicles, thus
forming nystatin–ergosterol channels within the membrane of
the proteoliposomes. A schematic diagram of this procedure is
shown in Fig. 3. After bilayer formation, protein incorporation
was initiated by injecting aliquots of the vesicle solution into
the upper well (Fig. 2c).
Results and discussion
The technique for protein delivery was tested and compared
with alternative techniques,
35 which were also successfully
reproduced within the microfluidic chip. The results are
presented below, together with a critical evaluation of the
N/E method compared with alternative approaches.
N/E vesicle fusion on chip
After formation of a BLM (using the air exposure method),
6.5 mL of 3 M KCl was injected into the upper well (cis side),
creating a salt gradient of 400 mM across the bilayer. Two
different populations of vesicles were then tested; the first
containing 10% ergosterol (molar ratio) and the second
containing 15% ergosterol (molar ratio), each containing
KcsA channels. Fig. 4a and b show current data of the fusion
for the two different vesicle types. The first (10% ergosterol) is
marked by a fast decay (0.1 s) of the current spike, while the
second is characterised by a slower (6 s) decay. Because of the
difference in ergosterol concentrations in the vesicles, disag-
gregation of the N/E pores occurs over a longer time in the
second case.
41 In both cases, single channel activity from the
KcsA is observed.
After fusion, the current returns to a stable baseline
(0.5–1 pA) with electrical activity characteristic of single
channel functionality (Fig 4c). This occurs approximately 80%
of the time, typically 1–2 min after a fusion. The buffer solution
on the cis side is then perfused with vesicle free low-salt buffer,
through the inlet and outlet channels (IN and OUT in Fig. 2c).
This action neutralises the salt gradient across the BLM.
This is necessary whenever a salt gradient is present because
the imbalance in electrolyte concentration causes an electro-
chemical potential to develop across the membrane, which is
superimposed on the applied voltage.
35,36 Buffer exchange also
removes the proteoliposomes that remain above the membrane,
minimising further fusion events. By monitoring the fusion
events, buffer exchange can be initiated when the required
number of active channels has been delivered to the BLM.
Fusion events can be increased by agitation of the vesicle
suspension in the upper well by removing and re-injecting a
few mL of buffer. This has the effect of increasing the probabi-
lity that vesicles come into contact with the bilayer membrane.
Microfluidic agitation of the vesicles is an alternative method
to the stirring used in conventional BLM apparatus,
39 and
provides a controlled method for inducing fusion.
Each 0.5 mL injection of vesicles dispenses approximately
10
10 proteoliposomes into the 40 mL volume of the upper well.
The vesicle size was measured by dynamic light scattering and
Fig. 3 Schematic diagram showing the procedure for protein reconstitution into vesicles. (a) Bio-Beads are mixed with a solution containing lipid-
detergent micelles with KcsA channels. (b) Bio-Beads slowly remove the detergent, resulting in the formation of unilamellar vesicles. (c) Nystatin
(Nys) is added to a solution of ergosterol (Erg)-containing proteoliposomes. (d) After 1 h, nystatin has inserted spontaneously into the vesicles,
forming N/E pores.
This journal is  The Royal Society of Chemistry 2007 Lab Chip, 2007, 7, 1176–1183 | 1179SEM (Fig. 5a and b), and was found to be in the range of
150–350 nm in diameter. Therefore, at the protein concentra-
tion used in the reconstitution, each vesicle contains on
average 5–10 KcsA channels.
Even though the number of vesicles is high, without conti-
nuous stirring the fusion rate is very low (0.1–1 fusion min
21);
an extremely small number of vesicles fuse with the bilayer.
Although calculations indicate that there are 5–10 KcsA
channels per vesicle, at most only 1–2 channel current steps are
observed after each fusion. This may mean that the channels
are characterised by a very low open state probability or that
they are reconstituted within the BLM in a non-functional
state. The concentration of protein channels in the vesicles
could be optimised to control the number of molecules inserted
per fusion event.
The main problem with the N/E technique is vesicle aggrega-
tion. The gradual formation of large multilamellar vesicles or
large lipid aggregates (small peak in Fig. 5b, in the range of
1–3 mm) results in the loss of fusogenic activity and can cause
BLM instability. Sonication or vortexing of the vesicle sample
decreases vesicle size
39 and aggregation, although not com-
pletely. Even so, this method is still reliable and provides a
route to chip-based electrophysiology measurements of ion
channels. As an example, an I–V curve for the KcsA channel is
presented in Fig. 4d, showing correlation with previously
reported data
27 obtained using a conventional system.
Incorporation of channels into the membrane was also
attempted by creating a salt gradient across the BLM using
proteoliposomes without N/E. Channel activity was only
occasionally obtained; there was no clear evidence of fusion
events, nor could the number of fusion events be evaluated,
rendering the procedure less robust and unpredictable. The N/E
vesicle fusion technique has the potential to be semi-automated,
for example using robotic injection of lipids and proteins,
perfusion of buffer with automated syringe pumps, etc. This
procedure could also be transferable to an array platform.
8,43
Alternative on-chip approach
Chip experiments using the ‘‘air-exposure’’ and N/E technique
require more complex procedures than a conventional BLM
system, but the methods could be automated. As recently
demonstrated,
43 the air-exposure technique is a reliable
method for on-chip BLM formation. The technique has also
been used for the simultaneous formation of three separate
BLMs on chip.
43 The horizontal, transparent, polymeric
chip structure allows not only for electrical recording of ion
channels and visualisation of the BLM formation, but has the
potential for single molecule (fluorescence) imaging, providing
a capability for simultaneous optical and electrical measure-
ment of ion channels.
Alternative approaches to protein insertion could be
implemented within the chip-based platform. For example, a
Fig. 4 (a) Electrical current recording for a fast vesicle fusion event (100 ms), where channel activity is observed immediately after fusion.
Liposome composition: 6 : 3 : 1 POPE : POPG : ergosterol (10% ergosterol). (b) Current recording showing vesicle fusion where channel activity is
observed during the current decay. Liposome composition: 5.5 : 3 : 1.5 POPE : POPG : ergosterol (15% ergosterol). (c) Single channel activity of
KcsA, after insertion into the BLM (150/550 mM KCl, 10 mM HEPES, pH 4/7.4). Applied potential is 75 mV. (d) I–V curve of KcsA in 100 mM
KCl, 10 mM HEPES, pH 4/7.4, compared with previously reported data.
36 Each data point on the I–V curve is the average of 20 current values for
opening events, at each applied potential.
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micromanipulated probe with a mixture of proteins and
agarose.
46 This is then inserted into the bilayer membrane,
depositing ion-channels.
A widely used technique (on a conventional BLM appara-
tus) for protein incorporation involves breaking and immedi-
ately reforming a BLM in the presence of protoliposomes.
Channel insertion occurs because the vesicles in suspension
fuse with the BLM during bilayer re-formation.
35
This procedure was implemented using our chip. After
forming a stable BLM, proteoliposomes were injected and
the membrane broken. This was achieved either using the
microfluidics or by applying a high voltage, causing electrical
breakdown. In the first case, after draining the upper well, the
Fig. 5 (a) SEM image of single protein-containing vesicles, average size 250 nm. (b) Dynamic light scattering of proteoliposome solution at 90u
angle. (c–d) Examples of transmembrane current traces obtained after proteoliposome incorporation, initiated by rupture and reforming of the
BLM. Using this method, the current baseline showed abnormal random current spikes, superimposed on KcsA channel activity.
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BLM rupture. In approximately 50% of cases, a bilayer could
be reformed by removing and re-injecting the buffer using the
microfluidics. However, ion-channel activity was not always
observed. On average, after reforming the BLM, channel
activity was observed 50% of the time. However, this process,
as shown in Fig. 5c–d, generally resulted in a baseline current
that was not stable. As shown in the figure, occasional jumps
were seen in the baseline current, probably due to instability in
the BLM. Single channel activity was observed, but the lifetime
of the BLM was substantially shortened using this method.
Lifetime and stability
Important characteristics of the system are the lifetime of the
channel-containing BLM and the breakdown voltage. This
data is summarised in Fig. 6. Two different experiments were
carried out. First, after a fusion event and following the
observation of channel activity, the bilayer capacitance
was monitored until the bilayer current increased leading to
eventual rupture of the membrane. Secondly, after channel
insertion, the applied potential across the BLM was varied in
order to determine the breakdown voltage.
Fig. 6a shows a capacitance trace for a protein-containing
BLM formed on-chip. As shown, the bilayer was stable for
more than 1 h after channel insertion. The time required for
BLM formation, vesicle injection, fusion events to occur and
stable channel activity to appear was 20–30 min, indicating
that a typical BLM lifetime is approximately 1.5–2 h. A bilayer
(formed on chip) without protein has a longer lifetime of 3
to 4 h.
43
Fig. 6b shows a current plot of a BLM formed on-chip with
ion-channels. The applied potential was increased incremen-
tally (from 100 mV) in steps of 25 mV, whilst simultaneously
measuring the current. The BLM was generally stable until the
applied potential reached 300 mV, typical of the maximum
potential applied to bilayers before breakdown. At this
voltage, the current jumps due to rupture of the BLM. The
figure shows that each time the potential is switched to zero,
prior to rupture, the current level returns to a zero baseline
value, confirming the stability of the on-chip protein-contain-
ing BLM.
Fig. 6 (a) Capacitance trace of a BLM formed on chip showing rupture after 4000 s. (b) Plot of the bilayer current for different voltage steps
applied intermittently to a BLM formed on chip containing KcsA channels, in order to determine the membrane breakdown voltage.
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We have demonstrated a method for the controlled delivery of
the K
+ channel KcsA to an artificial lipid bilayer formed in a
microfluidic chip. The protein was incorporated into vesicles
containing nystatin and ergosterol, which were then fused with
the bilayer. The method provides an electrical indication of
vesicle fusion. The procedure is shown to be a controllable and
reliable method for the delivery of non-spontaneously inserting
proteins into bilayers. The proposed protocol has potential for
use in developing high sensitivity, single molecule biosensors
based on artificial membrane systems and for general
electrophysiology experiments. The technique is also amenable
to semi-automation and for use in an array platform.
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